search
Back to results

Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction (Delfi)

Primary Purpose

Anterior Cruciate Ligament Tear

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Delfi
Standard rehabilitation
Sponsored by
University of Missouri-Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anterior Cruciate Ligament Tear

Eligibility Criteria

18 Years - 30 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients between 18-30 years of age.
  • Diagnosis of isolated anterior cruciate ligament (ACL) tear and pending ACL reconstruction.

Exclusion Criteria:

  • age <18 years old or >30 years old
  • Multi-ligament knee injury
  • Revision ACL reconstruction
  • History or peripheral vascular disease
  • History of deep vein thrombosis or pulmonary embolism
  • Any contraindication to moderated blood flow restriction therapy
  • Inability to comply with post-operative ACL reconstruction rehabilitation
  • If meniscal repair or a cartilage procedure is performed at the time of surgery that would preclude the patient from being able to follow the standard post-operative ACL rehabilitation.

Sites / Locations

  • Missouri Orthopaedic Institute

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard rehabilitation

Delfi moderated blood flow restriction

Arm Description

Patients will receive standard post-operative ACL rehabilitation

Patients will receive Delfi moderated blood flow post-operative ACL rehabilitation

Outcomes

Primary Outcome Measures

Muscle Strength
Compare mean peak muscle strength at 60 degrees of knee flexion (during extension) of the involved leg between the blood restriction and the control groups

Secondary Outcome Measures

Range of Motion
Compare the total Range of motion of the involved leg at 12 months between the Delfi and the control group
Tegner Activity Survey Score
Compare the Tegner Activity Survey score mean between the Delfi and the control group. Tegner activity level scale is a scale that aims to provide a standardized method of grading work and sporting activities. Tegner activity level scale is a graduated list of activities of daily living, recreation, and competitive sports. The patient is asked to select the level of participation that best describes their current level of activity and that before injury. The score varies from 0-10. A score of 0 represents sick leave or disability pension because of knee problems, whereas a score of 10 corresponds to participation in national and international elite competitive sports >6 score can only be achieved if the person participates in recreational or competitive sport.
Patient-Reported Outcomes Measurement Information System (PROMIS) Survey Score.
Compare the mean Patient-Reported Outcomes Measurement Information System Global Physical health row score (PROMIS) between the Delfi and the control group. PROMIS® (Patient-Reported Outcomes Measurement Information System) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. The Score is represented in a 0 to 100 scale. Zero is the worst possible outcome and 100 is teh best possible outcome
International Knee Documentation Committee (IKDC) Survey Score
Compare the mean International Knee Documentation Committee (IKDC) survey score between the delfi and the control group The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. Meanwhile, the sports activity subscale focuses on functions like going up and down the stairs, rising from a chair, squatting and jumping. The knee function subscale asks patients one simple question: how is their knee at present versus how was their knee prior to injury? Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.
Visual Analog Scale (VAS)
Compare the mean VAS scores (0 no pain - 10 worse pain ever) between the Delfi and the control group
Tight Circumference
Compare tight circumference of the involved leg between Delfi and the control group
KT-2000 Anterior Tibial Translation
Compare the mean anterior translation of the tibia between delfi and control groups anterior translation was measured using a KT-2000 device
CK Level
Compare CK levels at 12 months between delfi and control group
HGH Level
Compare mean HGH blood levels between the delfi and the control group
IGF Level
Compare the mean IGF blood values between delfi and control group

Full Information

First Posted
August 5, 2016
Last Updated
March 5, 2020
Sponsor
University of Missouri-Columbia
search

1. Study Identification

Unique Protocol Identification Number
NCT02911909
Brief Title
Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction
Acronym
Delfi
Official Title
Moderated Blood Flow Restriction After Anterior Cruciate Ligament
Study Type
Interventional

2. Study Status

Record Verification Date
March 2020
Overall Recruitment Status
Terminated
Why Stopped
Recruitment was unsuccessful
Study Start Date
October 1, 2017 (Actual)
Primary Completion Date
October 21, 2019 (Actual)
Study Completion Date
October 21, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri-Columbia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this study is to determine if there is a difference in post operative rehabilitation after anterior cruciate ligament (ACL) reconstruction surgery while using moderated blood flow therapy vs. standard physical therapy. All patients undergoing ACL reconstruction, between the ages of 18-30, that consent to taking part in the study, and meet eligibility criteria, will be included in the study. Patients will be followed for two years to determine any differences in muscle strength, thigh circumference, knee range of motion, pain, functional and activity levels, patient satisfaction, levels of Human growth hormone HGH), Insulin-like Growth Factor (IGF), and Creatine Kinase (CK), KT2000, and Lachman physical examination.
Detailed Description
The study will be a prospective, randomized, controlled trial between two treatment cohorts. A total of 50 patients will be enrolled in the study. Informed consent will be obtained in clinic prior to any surgical intervention, per the IRB protocol. Enrollees will receive a copy of the consent and HIPAA form. All patients that meet inclusion criteria who consent to participate in the study will then be randomly assigned to either the control group or moderated blood flow therapy group. Randomization will occur by autogenerated permutated 1:1 block randomization using electronic assignment from the orthopaedic research team prior to initiation of post-operative therapy. The control group will undergo standard of care, post-operative ACL reconstruction rehabilitation. The treatment group will also receive standard ACL rehabilitation combined with Delfi moderated blood flow restriction therapy. Patients will follow up at standard of care clinic visits and participate in the same standard of care physical therapy protocol for ACL reconstruction. Baseline measurements of thigh circumference, knee ROM, KT 2000, Lachman exam, and labs for HGH, IGF, and CK will be obtained preoperatively. Patients will also complete preoperative IKDC, Tegner, PROMIS, and VAS pain surveys. Measurements of thigh circumference and knee range of motion will occur at 2 week intervals post operatively. Strength testing will start at 6 weeks post-operatively. These measurements will occur during standard therapy sessions. KT 2000 and Lachman exam will be performed at 4, 6, 8, and 12 months post operatively. A standard functional return to sport evaluation will be performed at the 4, 6, 8, and 12 month postoperative visits. Labs for HGH, IGF, and CK will be drawn at 2, 6, 12, and 24 weeks. VAS pain scores will be recorded before and after each therapy session. The PROMIS, IKDC, and Tegner surveys will be given at 4, 6, 8, 12 month intervals. The study will conclude at 12 month follow up. All post-operative visits will be standard of care. No additional clinic visits will be required for this study. Background patient information will be collected including age, sex, BMI, and co-morbidities. The control group will be necessary to provide a baseline measure on which moderated blood flow therapy will be compared. Blinding of the subject will not be possible as the patient will be able to recognize if they have or have not had the moderated blood flow (Delfi) device applied during therapy and application of a sham-device is not practical or considered standard of care. Evaluators performing measurements will be blinded to the patient's treatment group during assessment of muscle strength, thigh circumference, knee range of motion, Lachman exam, and KT2000. Surgeons will also be blinded to the respective treatment groups. All other outcome measures are objective and quantitative.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anterior Cruciate Ligament Tear

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard rehabilitation
Arm Type
Active Comparator
Arm Description
Patients will receive standard post-operative ACL rehabilitation
Arm Title
Delfi moderated blood flow restriction
Arm Type
Experimental
Arm Description
Patients will receive Delfi moderated blood flow post-operative ACL rehabilitation
Intervention Type
Device
Intervention Name(s)
Delfi
Other Intervention Name(s)
moderated blood flow restriction device
Intervention Description
Patients will receive standard of care post-operative ACL reconstruction rehabilitation plus the Delfi moderated blood flow restriction therapy.
Intervention Type
Other
Intervention Name(s)
Standard rehabilitation
Intervention Description
Patients will receive standard of care post-operative ACL reconstruction rehabilitation
Primary Outcome Measure Information:
Title
Muscle Strength
Description
Compare mean peak muscle strength at 60 degrees of knee flexion (during extension) of the involved leg between the blood restriction and the control groups
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Range of Motion
Description
Compare the total Range of motion of the involved leg at 12 months between the Delfi and the control group
Time Frame
12 months
Title
Tegner Activity Survey Score
Description
Compare the Tegner Activity Survey score mean between the Delfi and the control group. Tegner activity level scale is a scale that aims to provide a standardized method of grading work and sporting activities. Tegner activity level scale is a graduated list of activities of daily living, recreation, and competitive sports. The patient is asked to select the level of participation that best describes their current level of activity and that before injury. The score varies from 0-10. A score of 0 represents sick leave or disability pension because of knee problems, whereas a score of 10 corresponds to participation in national and international elite competitive sports >6 score can only be achieved if the person participates in recreational or competitive sport.
Time Frame
12 months
Title
Patient-Reported Outcomes Measurement Information System (PROMIS) Survey Score.
Description
Compare the mean Patient-Reported Outcomes Measurement Information System Global Physical health row score (PROMIS) between the Delfi and the control group. PROMIS® (Patient-Reported Outcomes Measurement Information System) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults and children. It can be used with the general population and with individuals living with chronic conditions. The Score is represented in a 0 to 100 scale. Zero is the worst possible outcome and 100 is teh best possible outcome
Time Frame
12 months
Title
International Knee Documentation Committee (IKDC) Survey Score
Description
Compare the mean International Knee Documentation Committee (IKDC) survey score between the delfi and the control group The IKDC Questionnaire is a subjective scale that provides patients with an overall function score. The questionnaire looks at 3 categories: symptoms, sports activity, and knee function. The symptoms subscale helps to evaluate things such as pain, stiffness, swelling and giving-way of the knee. Meanwhile, the sports activity subscale focuses on functions like going up and down the stairs, rising from a chair, squatting and jumping. The knee function subscale asks patients one simple question: how is their knee at present versus how was their knee prior to injury? Scores are obtained by summing the individual items, then transforming the crude total to a scaled number that ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.
Time Frame
12 months
Title
Visual Analog Scale (VAS)
Description
Compare the mean VAS scores (0 no pain - 10 worse pain ever) between the Delfi and the control group
Time Frame
12 months
Title
Tight Circumference
Description
Compare tight circumference of the involved leg between Delfi and the control group
Time Frame
12 months
Title
KT-2000 Anterior Tibial Translation
Description
Compare the mean anterior translation of the tibia between delfi and control groups anterior translation was measured using a KT-2000 device
Time Frame
12 months
Title
CK Level
Description
Compare CK levels at 12 months between delfi and control group
Time Frame
12 months
Title
HGH Level
Description
Compare mean HGH blood levels between the delfi and the control group
Time Frame
12 months
Title
IGF Level
Description
Compare the mean IGF blood values between delfi and control group
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients between 18-30 years of age. Diagnosis of isolated anterior cruciate ligament (ACL) tear and pending ACL reconstruction. Exclusion Criteria: age <18 years old or >30 years old Multi-ligament knee injury Revision ACL reconstruction History or peripheral vascular disease History of deep vein thrombosis or pulmonary embolism Any contraindication to moderated blood flow restriction therapy Inability to comply with post-operative ACL reconstruction rehabilitation If meniscal repair or a cartilage procedure is performed at the time of surgery that would preclude the patient from being able to follow the standard post-operative ACL rehabilitation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Cook
Organizational Affiliation
University of MO-Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Missouri Orthopaedic Institute
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65212
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Moderated Blood Flow Restriction After Anterior Cruciate Ligament Reconstruction

We'll reach out to this number within 24 hrs